Reumavid is a questionnaire investigating the consequences of the covid-19 pandemic on people living with rheumatic conditions in United Kingdom.
The survey is aimed at people living with rheumatic diseases who are experiencing confinement due to COVID-19.
Its aim is to describe the consequences of the pandemic on the evolution of the disease, support services, healthcare, the quality of life and the emotional well-being of people living with rheumatic diseases.
This study is promoted by National Axial Spondyloarthritis Society (NASS), National Rheumatoid Arthritis Society (NRAS), and Arthritis Action, and conducted by the Health & Territory Research (HTR) of the University of Seville, with the support of Novartis Pharma AG.…
Read more of this article
Pain UK would like to alert you to the work of the Covid-19 Global Rheumatology Alliance, an organisation established to “collect, analyze and disseminate information about COVID-19 and rheumatology to patients, physicians and other relevant groups to improve the care of patients with rheumatic disease.”
Research funding awarded by Nuffield Foundation’s Oliver Bird Fund
The Productive Healthy Ageing team at Public Health England are developing the research framework for healthy ageing and would like to invite you to take part in a survey to support this process. They will use the survey to identify the gaps in research on healthy ageing and to produce a list of the highest priority research questions to influence future research proposals.
In October 2019 a report on chronic pain services and management from a patient and healthcare professional perspective was published. The research has highlighted a number of key insights and themes for how respondents felt that chronic pain services can be improved and made more equitable in the future. Pain is one of the common factors across all MSK conditions, so this is something which ARMA will be following up in the future.
The National Early Inflammatory Arthritis Audit (NEIAA) collects information on all new patients over the age of sixteen seen in specialist rheumatology departments with suspected inflammatory arthritis in England and Wales. The first report was published in October. The audit assesses seven key metrics of care provided for people with new symptoms of arthritis attending rheumatology services for the first time and makes recommendations for services, educators and commissioners.